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Figure 1. Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and infection rates, 2003. PPE, personal protective equipment.
Paradoxical Increase
in Methicillin-Resistant
Staphylococcus aureus
Acquisition Rates Despite
Barrier Precautions and
Increased Hand Washing
Compliance during an
Outbreak of Severe Acute
Repiratory Syndrome
Sir—We read with interest the report by
Yap et al. [1] regarding the increased rates
of methicillin-resistant Staphylococcus au-
reus (MRSA) isolation in the intensive care
unit (ICU) during an outbreak of se-
vere acute respiratory syndrome (SARS)
in Hong Kong. The SARS outbreak in Sin-
gapore, which lasted from 4 March 2003
to 11 May 2003, also led to the adoption
of heightened infection-control measures,
including mandatory universal use of per-
sonal protective equipment (PPE) con-
sisting of disposable long-sleeved gowns,
gloves, goggles, and N95 masks by health
care workers for all patient contacts. Com-
pulsory training on the proper donning
and discarding of PPE was instituted, and
compliance with hand washing was re-
inforced. Observers were employed to en-
sure that these measures were followed by
the ward staff. In addition, all patients with
undifferentiated fever were nursed in sin-
gle isolation rooms until the cause of their
fever was ascertained. Whereas the data
reported by Yap et al. [1] was confined to
the ICU, we studied the effect of these
measures on hospital-wide nosocomial
MRSA infection and bacteremia rates in
the National University Hospital, a 1000-
bed teaching facility in Singapore.
MRSA bacteremia and infection rates
were determined by surveillance of non-
duplicative isolates identified in the mi-
crobiology laboratory from January 2003
through December 2003 (figure 1). Hand
washing compliance was determined by
trained observers in 2 surveys involving a
total of 1004 subjects; the first survey, in-
volving 829 subjects, was done in February
2003 (before the SARS outbreak), and the
second survey, involving 175 subjects, was
done in June 2003 (after the SARS out-
break). The overall rate of compliance
with hand washing increased from 33.4%
in February 2003 to 87.4% in June 2003
( ). However, we too were unablePp .01
to detect a corresponding decrease in
MRSA infection rates (figure 1). Paradox-
ically, increases in the rates of MRSA in-
fection and possibly MRSA bacteremia
were observed, despite the use of intense
infection-control measures during the ep-
idemic period.
Like the findings reported by Yap et al.
[1], our findings seem to suggest that the
universal use of gloves and gowns did not
produce the expected decrease in the rate
of nosocomial cross-infection [2, 3]. Al-
though protective to health care work-
ers, inanimate objects (such as gloves and
gowns) have been implicated as reservoirs
of MRSA [4, 5]. In addition, although we
were able to document a marked improve-
ment in hand hygiene compliance, we
were unable to show expected reductions
in the rate of nosocomial infection [6, 7].
We suspect that despite—or perhaps be-
cause of—the increased emphasis on hand
hygiene, compliance with glove change be-
tween patient contacts was reduced, and
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this may have led to increased transmis-
sion of multidrug-resistant nosocomial
pathogens on the gloved hands of health
care workers [5]. Another possible ex-
planation for the paradoxical increase in
MRSA rates during the SARS outbreak
could be the shunting of limited infec-
tion-control resources to SARS case sur-
veillance and epidemiology and away
from mainstream infection-control ac-
tivities, thus compromising the effec-
tiveness of baseline control measures
against nosocomial infections.
As our data reinforce, during periods of
intense alert for novel emerging patho-
gens, such as SARS coronavirus and avi-
an influenza virus, it is imperative that
“conventional” practices of infection con-
trol not be overlooked, because they re-
main essential for the control of infection
with endemic nosocomial pathogens in
our midst.
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Outbreak of Methicillin-
Resistant Staphylococcus
aureus Infection Associated
with an Outbreak of Severe
Acute Respiratory Syndrome
Sir—We read with great interest the re-
cent article by Yap et al. [1]. The au-
thors report a significant increase in the
methicillin-resistant Staphylococcus aureus
(MRSA) acquisition rate, with a very high
rate of ventilator-associated pneumonia—
caused mainly by MRSA—in patients with
severe acute respiratory syndrome (SARS)
in an intensive care unit (ICU) that ad-
mitted only patients with SARS. Para-
doxically, this increase occurred after
infection-control measures (including the
wearing of gloves and gowns at all times)
were upgraded because of the SARS out-
break and despite a low importation rate
of MRSA into the ICU.
Yap et al. [1] provide 3 possible expla-
nations for this observation. First, the
practice of wearing gloves at all times may
have led to poor compliance with hand
hygiene, and the routine wearing of long-
sleeved gowns, which were not changed
between contact with patients, could also
have contributed to cross-transmission of
MRSA. Second, the heavy use of anti-
microbials active against gram-negative
organisms could have promoted the ov-
ergrowth of MRSA. Third, the SARS-
associated coronavirus (SARS-CoV) may
predispose patients to secondary infection
with S. aureus.
We agree with these hypotheses, but we
disagree with the conclusion that “cross-
transmission of MRSA may be increased
… if the [infection-control] measures in-
cluded excessive use of gloves and gowns”
[1, p. 515]. An alternative explanation for
the significant increase in the rate of
MRSA acquisition may be a viral-bacterial
interaction between SARS-CoV and S. au-
reus, leading to an explosive airborne dis-
persal of S. aureus and a very efficient
transmission of MRSA from colonized to
noncolonized patients (the “cloud phe-
nomenon”). This phenomenon was de-
scribed by Eichenwald et al. [2], who
showed that newborn infants who are na-
sally colonized with S. aureus produce sig-
nificant airborne S. aureus dispersal and
become highly contagious after infection
with a respiratory virus. These babies
caused explosive outbreaks of S. aureus
infection in nurseries. Because they were
literally surrounded by clouds of bacteria,
they were called “cloud babies” [2]. We
have recently shown that the same mech-
anism also occurs in certain adult nasal
S. aureus carriers (“cloud adults”) [3–5].
Reports in the literature describe single
health care workers nasally colonized with
S. aureus who originated nosocomial S. au-
reus epidemics while experiencing a viral
infection of the upper respiratory tract. This
confirms that “cloud adults” can cause out-
breaks [3, 6, 7]. Our data also indicate that
clothing contaminated with S. aureus can
amplify the dispersal of these bacteria into
the air [4, 5], in agreement with previous
observations [8, 9].
In conclusion, aerial dissemination of
MRSA because of the “cloud phenome-
non” may be the main reason for the de-
scribed epidemic of MRSA infection. This
may have occurred as a result of direct
aerial dissemination or as a result of heavy
contamination of the environment of col-
onized patients (including contamination
of patient bedclothes or health care worker
gowns). This, in combination with diffi-
culties associated with frequently changing
gloves and gowns, may have greatly facil-
itated MRSA cross-infection during the
SARS outbreak.
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Reply to Bassetti et al.
Sir—We appreciate the comments on our
article [1] by Bassetti et al. [2]. We agree
that the fourth hypothesis, relating to the
“cloud” phenomenon [3–5], may contrib-
ute to the spread of methicillin-resistant
Staphylococcus aureus (MRSA).
However, we do not think that the
cloud phenomenon is the main reason for
the MRSA epidemic we describe [1]. Dur-
ing the study period, all staff in the inten-
sive care unit (ICU) wore N95 masks. Be-
cause masks are effective in reducing the
dispersal of MRSA [5], “cloud” health care
workers would be an unlikely explanation
for the epidemic. For patients who carry
S. aureus in the nares, it appears that ac-
tive breathing, sneezing, nose blowing, or
snorting to the open air are important
in the formation of airborne bacterial
“clouds.” We would like to point out that
it is unlikely that our patients performed
these activities to a significant extent. Un-
like in patients with rhinovirus infection,
nasal symptoms are rare in patients with
severe acute respiratory syndrome. Fur-
thermore, precautions to control aerosol
spread in the ICU were extremely strict
during the period of the SARS outbreak.
The majority of patients received me-
chanical ventilation. All circuit connection
and disconnection procedures were per-
formed with extreme caution, and all suc-
tioning was conducted in closed-suction
systems. A high-efficiency bacterial/viral
filter was incorporated into each breathing
circuit, and the exhalation port of the ven-
tilator was connected to scavenging sys-
tems. Surgical masks were worn by spon-
taneously breathing patients with nasal
cannula or oxygen masks. For patients
requiring high-flow oxygen, tight-fitting
masks with filters were used. Use of Ven-
turi-type masks, nebulization, and non-
invasive positive-pressure ventilation were
all avoided. Therefore, “explosive” disper-
sal of droplets or aerosols would have been
unlikely.
During the outbreak of SARS, there was
a hospital (Queen Mary Hospital; Pok-
fulam, Hong Kong) that explicitly banned
“gloving all the time” and instead pro-
moted glove use “only when indicated”
and meticulous hand washing. This hos-
pital managed a total of 52 cases of SARS,
which is a substantially lower number of
cases than were treated at our institution
(Prince of Wales Hospital, Hong Kong).
There was no change in the rate of MRSA
acquisition in the ICU or in the hospi-
tal in general (W. H. Seto, personal
communication).
In a health care environment, patient
contact is the main mode of transmission
for MRSA. During the period we reported,
gloves were worn at all times by health
care workers, and hands were not neces-
sarily always washed between the chang-
ing of gloves [1]. These practices—to-
gether with the excessive use of antibiotics,
including fluoroquinolones—may be the
main driving factors underlying the out-
break of MRSA infection. After removal
of gloves, hands are commonly contami-
nated with nosocomial pathogens such as
MRSA, with contamination rates of up to
50% [6]. Occult breaks in latex gloves can
cause substantial contamination of the
hands [7], and it has been reported that
20% of latex gloves that had passed the
watertight test allowed penetration of bac-
teria to the hands [8].
The “cloud” phenomenon is an in-
teresting subject, and its relevance in the
nosocomial transmission of pathogens de-
serves further evaluation. Health care work-
ers should understand that wearing of
gloves is not a substitute for hand washing.
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Strongyloides stercoralis
Infection as a Manifestation
of Immune Restoration
Syndrome?
Sir—Kim and Lupatkin [1] describe a pa-
tient with fever, eosinophilia, hepatitis,
and Strongyloides stercoralis larvae in stool,
as revealed by microscopy. These clinical
features developed after diagnosis of
HIV-1 infection and commencement of
HAART and are attributed by the authors
to immune restoration. Empirical therapy
for cerebral toxoplasmosis was also initi-
ated with pyrimethamine and sulfadiazine,
as was therapy with dexamethasone. The
patient’s condition responded to standard
therapy with ivermectin.
A more likely explanation for this case
is that the patient experienced an exac-
erbation of subclinical S. stercoralis infec-
tion following the institution of high-dose
corticosteroid therapy. Corticosteroid
therapy has long been recognized as the
major risk factor for development of se-
vere disease and disseminated strongylo-
idiasis in people with asymptomatic car-
riage of S. stercoralis [2, 3]. Furthermore,
it has been noted that it is rare to develop
disseminated strongyloidiasis in the ab-
sence of corticosteroid therapy. Although
it was initially hypothesized that the im-
munosuppression secondary to HIV in-
fection would result in an increased in-
cidence of disseminated strongyloidiasis,
such a rise in incidence has not been ob-
served. For example, a general lack of cor-
relation between HIV infection and stron-
gyloides hyperinfection has been observed
in regions where both are endemic, such
as sub-Saharan Africa and Brazil [4]. We,
therefore, suggest that the case presented
may merely reflect S. stercoralis carriage
progressing to clinical disease following
the use of dexamethasone.
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Tropical Pulmonary
Eosinophilia
Sir—In a recent article, Boggild et al. [1]
tackled the problem of imported cases of
tropical pulmonary eosinophilia (TPE).
However, the diagnostic procedure that
was used raised some concerns about the
accuracy of the filarial etiology of the re-
ported syndrome. TPE, as underlined by
Boggild et al. [1], is characterized by
pulmonary infiltrates and blood eosino-
philia. This clinical picture can have var-
ious noninfectious or infectious etiologies;
among the helminthiases, these include
ancylostomiasis, strongyloidiasis, and vis-
ceral larva migrans (a major form of tox-
ocariasis), which have been recognized as
parasitic etiologies of pulmonary eosino-
philia [2, 3]. Toxocariasis, a helmintho-
zoonosis found worldwide, appears to be
an especially common cause of pneumo-
nitis with eosinophil infiltrates; 9 of 57 Ar-
gentine pediatric patients displayed this
symptom [4].
How helminthiases other than ban-
croftian filariasis were ruled out was not
reported by Boggild et al. [1]. Moreover,
the diagnosis of filarial TPE was depen-
dent on the results of an ELISA, the exact
procedure of which was not described.
ELISA that uses extracts of heterologous
filaria worms is known to cross-react with
serum samples from other roundworm
diseases [5], but the use of recombinant
antigens could resolve this problem [6].
Given these facts, we were surprised that
Boggild et al. [1] did not test for circu-
lating filarial antigens to ascertain the
bancroftian origin of their TPE cases.
Since its first use in the field by the middle
of the 1990s [7], detection of the so-called
Og4C3 antigen, by either immunochro-
matography (“card test”) or ELISA, has
proven to be a specific and sensitive
method for the immunodiagnosis of
Wuchereria bancrofti infections [8]. It is
currently considered a major tool for the
control of lymphatic filariasis [9]. We rec-
ognize that this test is unable to detect
Brugia malayi infections, but none of the
patients included in the study by Boggild
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Table 1. Characteristics of 264 therapeutic recommendations made for
178 patients
Recommendation
No. of
recommendations
made
No. (%) of
recommendations
followed
Commence antibiotic treatment 69 69 (100)
Change antibiotic treatment 60 56 (93.3)
Discontinue antibiotic treatment 135 128 (94.8)
Total 264 250 (94.7)
et al. [1] was from an area where Brugia
lymphatic filariasis is endemic. Since the
end of 2001, we have routinely used the
commercial ELISA version of the Og4C3
assay (Tropbio). Of the patients attend-
ing the consultation unit of our hospital
who were immigrants from or residents
of a tropical area, 165 were tested by ELISA
(Bordier Affinity Products) for the pres-
ence of filarial antibodies and Og4C3, on
the basis of the presence of clinical signs
consistent with a filarial infection (ban-
croftiasis, loiasis, or onchocerciasis), and/
or blood eosinophilia. Of 17 patients who
had significant filarial ELISA results (op-
tical density of .900), 1 patient was
found to be infected with hookworm, 5
had strongyloidiasis, and 2 probably had
toxocariasis. None of the cross-reacting
serum samples from these patients had
detectable Og4C3 antigen.
Therefore, the possibility of bancroftian
filariasis in patients 2, 8, 9, 13, and 15 from
the study by Boggild et al. [1], who had a
moderate level of antifilarial antibodies,
appears to be questionable. The efficacy
of diethylcarbamazine therapy cannot be
considered circumstantial evidence of fi-
larial infection, because this drug was
found to be effective for treatment of
toxocariasis [10].
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Impact of Recommendations
by Clinical Microbiologists
on Antimicrobial Treatment
in the Intensive Care Units
of a Dublin Teaching
Hospital
Sir—We read with interest the article by
Lo et al. [1] regarding adherence to rec-
ommendations made during infectious
diseases (ID) consultations. The data,
which were from a prospective cohort
study of 465 consultations at 2 large ter-
tiary care centers, revealed an overall rate
of compliance to recommendations of
80%. Compliance was higher when rec-
ommendations involved therapy, com-
pared with those that involved diagnostic
procedures (92% vs. 70%). Only 5% of
consultations were made in the surgical
intensive care unit (ICU). In his editorial
commentary, Tenenbaum [2] highlights
the fact that, at his institution, ID physi-
cians have little impact when it comes to
altering inappropriate antimicrobial use in
the ICU. In this era of increasing concern
about antibiotic stewardship, there have
been a number of studies investigating the
impact of ID consultative care on patient
treatment in various settings [3–5].
In light of the findings by Lo et al. [1]
and with regard to the difficulties high-
lighted by Tenenbaum [2], we would like
to outline the consultative practice at the
ICUs at our institution. Beaumont Hos-
pital (Dublin, Ireland) is a 650-bed tertiary
referral center and contains the national
neurosurgical center for the Republic of
Ireland. There is a 10-bed general ICU and
an 11-bed neurosurgical ICU, both of
which are open. On a daily basis, from
Monday to Friday, a specialist registrar
and/or consultant from the clinical mi-
crobiology service, together with a spe-
cialist registrar and/or consultant in in-
tensive care medicine, review data for all
patients in both ICUs. At other times, ad-
vice on patient treatment is given, if re-
quired, by the consultant clinical micro-
biologist on call. Recommendations are
made on these daily rounds on the basis
of clinical features, radiological findings,
laboratory results (including microbiolog-
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ical data), changes in ventilatory support,
and inotrope requirements, etc., to com-
mence antimicrobial treatment. Recom-
mendations are also made regarding di-
agnostic procedures.
Over a 3-month period from 1 May
to 31 July 2004, using clinical microbiology
service records, we retrospectively reviewed
compliance with our therapeutic recom-
mendations for 178 patients. Treatment
modification (i.e., initiation, change, or dis-
continuation of antibiotic treatment) was
recommended for 128 patients. In total,
there were 264 therapeutic recommenda-
tions during the period (table 1).
These results demonstrate that consul-
tation with a laboratory-based clinical mi-
crobiology service, delivered in collabo-
ration with intensive care medicine, can
ensure a very high degree of compliance
with treatment modifications. The high
level of acceptance of this service may be
related to the fact that care is delivered by
medically qualified clinical microbiologists
who have undergone postgraduate train-
ing in general internal medicine and have
then undertaken 5 years of training
about all aspects of infection—diagnosis,
prevention, and therapy. In addition,
clinical microbiologists supervise hospital
microbiology laboratories, so that a single
individual ensures a direct flow of infor-
mation from bench to bedside, resulting
in patient-focused care.
In many US hospitals, microbiology
laboratories are supervised by scientists
and/or managers, patient consultation and
antibiotic advice is provided by ID phy-
sicians, surveillance of hospital-acquired
infection is undertaken by a hospital ep-
idemiologist, infection prevention is the
remit of infection-control practitioners,
and liaison between the microbiology lab-
oratory and the attending physician is un-
dertaken by clinical pharmacists. In this
arrangement, a lack of integration may re-
sult in inadequate communication be-
tween divisions, leading to a poor uptake
of therapeutic advice. In the integrated
model, the clinical microbiologist has a
pivotal role in all aspects of “infection” as
it pertains to the ICU. The system in op-
eration in this hospital, as in much of Eu-
rope, improves antimicrobial stewardship
and optimizes patient care.
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